Interferon-γ and IL-27 positively regulate type 1 regulatory T cell development during adaptive tolerance
Strong T cell receptor (TCR) and interleukin (IL)-27 signaling influence type 1 regulatory (Tr1) T cell development, but whether other signals determine their differentiation is unclear. Utilizing Tg4 TCR transgenic mice, we established a model for rapid Tr1 cell induction. A single high dose of [4Y]-MBP peptide drove the differentiation of <i>Il10</i> <sup>+</sup> T cells with Tr1 cell mRNA and protein signatures. Kinetic transcriptional and phenotypic analyses revealed that the Tr1 cell module was transient and preceded by <i>Ifng</i> transcription in other CD4<sup>+</sup> T cells. Changes in Tr1 cell frequency correlated with altered macrophage activation, while neutralization of interferon (IFN)γ reduced Tr1 cell frequency and the TCR signal strength markers Nur77, inducible T cell costimulator (ICOS), and OX40. Antibody depletion experiments inferred that the relevant source of IFNγ was not natural killer (NK) cell derived. Additionally, blocking IL-27 in combination with IFNγ neutralization additively reduced Tr1 cell frequency <i>in vivo</i>. These findings reveal that IFNγ has a non-redundant role in augmenting Tr1 cell differentiation <i>in vivo</i>.
Authors
- David A.J. Lecky (ORCID: https://orcid.org/0000-0002-9333-5605)
- Sophie Rouvray (ORCID: https://orcid.org/0009-0008-8828-1447)
- David C. Wraith (ORCID: https://orcid.org/0000-0003-2147-5614)
- Lozan Sheriff (ORCID: https://orcid.org/0000-0001-8364-9080)
- Alastair Copland (ORCID: https://orcid.org/0000-0003-3117-3935)
- David Bending (ORCID: https://orcid.org/0000-0003-0071-1163)
- Rebecca A. Drummond (ORCID: https://orcid.org/0000-0001-5424-7074)
- L. George
Institutions
- University of Birmingham (GB)
Publication Details
- Journal
- iScience
- Published
- 2025-03-31
- DOI
- https://doi.org/10.1016/j.isci.2025.112308
- Citations
- 1
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Wellcome Trust
- Lister Institute of Preventive Medicine
- Medical Research Council